2017-11-06T14:28:35-06:00 2017-06-30 521511275 RAFFA PC 1899 L STREET NW SUITE 850 WASHINGTON DC 20036 990 2016-07-01 237135845 THE FOUNDATION FIGHTING BLINDNESS INC FOUN 4104230600 7168 COLUMBIA GATEWAY DRIVE NO 100 COLUMBIA MD 21046 ANNETTE HINKLE CPA CHIEF STRATEGY OFFICER/CFO 4104230600 2017-11-06 1 FRANK H SMITH P00639053 2028225000 2017-11-06 207.238.152.33 2017-11-06 15:28:24 ES P FFA2BC33170E4325356C19B39EDBBFEB056B45D7 DAB48F1DB241BD34F7C51364F39BEF4B5B3312C9 2016 2021-01-29 14:40:06Z ANNETTE HINKLE CPA 7168 COLUMBIA GATEWAY DRIVE NO 100 COLUMBIA MD 21046 67920375 0 X WWW.FIGHTBLINDNESS.ORG X 1971 MD FFB FUNDS RESEARCH TO DISCOVER CAUSES AND CURES FOR RETINAL DISEASES LEADING TO BLINDNESS. 20 20 87 2500 0 0 68515510 22746532 398822 136003 2380320 2186159 599793 -478510 71894445 24590184 14860576 15462635 0 0 6628167 6755632 1098884 593653 7222864 5979288 5863405 28566915 28675325 43327530 -4085141 158683383 154220569 15180623 16294861 143502760 137925708 X THE MISSION OF THE FOUNDATION FIGHTING BLINDNESS, INC. (FFB) IS TO DRIVE THE RESEARCH THAT WILL PROVIDE PREVENTIONS, TREATMENTS AND CURES FOR PEOPLE AFFECTED BY RETINITIS PIGMENTOSA, MACULAR DEGENERATION, USHER SYNDROME, AND THE SPECTRUM OF RETINAL DEGENERATIVE DISEASES. 0 0 17214850 15462635 132603 RESEARCH - THE FOUNDATION FIGHTING BLINDNESS, INC. (FFB) FUNDED RESEARCHERS ARE ACHIEVING REMARKABLE SUCCESS IN DISCOVERING, TESTING AND DELIVERING TO PATIENTS A WIDE RANGE OF PROMISING THERAPIES TO PREVENT, STOP THE PROGRESSION OF, AND CURE BLINDNESS DUE TO RETINAL DEGENERATIVE DISEASES. FFB AND ITS SUBSIDIARY, THE FFB CLINICAL RESEARCH INSTITUTE, FUND CRITICAL TRANSLATIONAL RESEARCH OF GENE, STEM CELL AND PHARMACEUTICAL THERAPIES THAT HAVE SIGNIFICANTLY RESTORED VISION IN PATIENTS DURING CLINICAL TRIALS. ONE SUCH THERAPY IS CURRENTLY UNDER REVIEW FOR APPROVAL BY THE U.S. FOOD AND ADMINISTRATION.(CONTINUED ON PAGE 53)FFB HAS SET ASIDE $47.5 MILLION FOR ACTIVE RESEARCH PROJECTS THAT HAVE FUTURE RESEARCH MILESTONES AND HAS SET ASIDE $73 MILLION FOR NEW INNOVATIVE OPPORTUNITIES TO BE AWARDED IN THE NEAR FUTURE. THIS GIVES FFB THE FLEXIBILITY AND OPPORTUNITY TO INVEST IN UPCOMING LARGE-SCALE STUDIES AND CLINICAL TRIALS WHEN THEY BECOME AVAILABLE. 1608989 3400 PUBLIC HEALTH EDUCATION - FFB FUNDED HEALTH EDUCATION PROGRAMS REACH OVER MILLIONS OF PEOPLE ON AN ANNUAL BASIS THROUGH EDUCATIONAL SEMINARS AND SPEAKER SERIES PROGRAMS, THE FFB WEBSITE AND PUBLIC SERVICE ANNOUNCEMENTS, NEWSLETTERS, SOCIAL MEDIA, A BLOG, AND EARNED MEDIA COVERAGE. 18823839 1 1 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 1 0 0 1 1 0 1 1 1 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 0 1 215 0 1 87 1 0 0 0 0 0 1 1 0 0 0 0 X 20 20 1 0 0 0 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 AL AK AR CA CO CT FL GA HI KS IL IN MA ME MD MI MN MS NH NJ NM NY NC OH OK OR PA SC TN UT VA WA WV WI X X ANNETTE HINKLE CPA 4104230600 7168 COLUMBIA GATEWAY DRIVE 100 COLUMBIA MD 21046 X DAVID BRINT CHAIRMAN 10.00 1.00 X X 0 0 0 GORDON GUND DIRECTOR - CHAIRMAN EMERITUS 1.00 1.00 X X 0 0 0 JOEL DAVIS VICE CHAIRMAN 1.00 X X 0 0 0 EDWARD RUSSNOW VICE CHAIRMAN 1.00 X X 0 0 0 JEREMIAH H SHAW VICE CHAIRMAN (UNTIL 07/2016) 1.00 X X 0 0 0 JONATHAN STEINBERG MD VICE CHAIRMAN 1.00 X X 0 0 0 WARREN THALER VICE CHAIRMAN 1.00 X X 0 0 0 EDWARD H GOLLOB BOD PRESIDENT EMERITUS 1.00 1.00 X X 0 0 0 HAYNES LEA TREASURER 1.00 X X 0 0 0 YVONNE CHESTER SECRETARY 1.00 X X 0 0 0 STEVE ALPER DIRECTOR 1.00 X 0 0 0 EDWARD BABIN DIRECTOR 1.00 X 0 0 0 WILLIAM CARTY DIRECTOR 1.00 X 0 0 0 JASON FERREIRA DIRECTOR 1.00 X 0 0 0 MARILYN GREEN DIRECTOR 1.00 X 0 0 0 ROBERT HEIDENBERG DIRECTOR 1.00 1.00 X 0 0 0 SHERRI KROONENBERG DIRECTOR (UNTIL 09/2016) 1.00 X 0 0 0 JANNI LEHRER-STEIN DIRECTOR 1.00 X 0 0 0 BRADFORD MANNING DIRECTOR 1.00 X 0 0 0 EVAN MITTMAN DIRECTOR 1.00 X 0 0 0 KAREN PETROU DIRECTOR 1.00 X 0 0 0 BRUCE SAWYER DIRECTOR (UNTIL 12/2016) 1.00 X 0 0 0 MOIRA SHEA DIRECTOR (UNTIL 07/2016) 1.00 X 0 0 0 MARYROSE SYLVESTER DIRECTOR 1.00 X 0 0 0 WILLIAM T SCHMIDT CHIEF EXECUTIVE OFFICER 40.00 1.00 X 354215 0 9941 PATRICIA ZILLIOX PHD CHIEF DRUG DEVELOPMENT OFFICER 1.00 40.00 X 0 234752 9202 STEPHEN M ROSE PHD CHIEF RESEARCH OFFICER 40.00 X 225486 0 28957 ANNETTE HINKLE CPA CHIEF STRATEGY OFFICER/CFO 20.00 1.00 X 101465 0 3040 PATRICIA A DUDLEY CHIEF HUMAN RESOURCE OFFICER 40.00 X 146480 0 25760 LORRAINE HIRSCH CPA CHIEF FINAN. OFFICER - UNTIL 03/2017 40.00 1.00 X 178942 0 21271 VALERIE NAVY-DANIELS CHIEF DEVELOPMENT OFFICER 40.00 X 259338 0 29685 RHEA FARBERMAN DEPUTY CHIEF, DEVELOPMENT 40.00 X 154126 0 12815 HOPE KESSLER SR. DIRECTOR, MAJOR GIFTS 40.00 X 236066 0 17599 BRIAN MANSFIELD PHD DEPUTY CHIEF RESEARCH OFFICER 40.00 X 162710 0 26897 MICHELE MERCER SR. DIRECTOR DATABASE 40.00 X 110161 0 18695 1928989 234752 203862 10 0 1 0 CATALYST CREATIVITY INC 150 LAS VEGAS BLVD N STE 2213 LAS VEGAS NV 89101 FUNDRAISING COUNSEL 517013 MARRIOTT BALTIMORE WATERFRONT 700 ALICEANNA STREET BALTIMORE MD 21202 EVENT FACILITY 327316 AAB PRODUCTIONS INC 387 GRAND STREET K705 NEW YORK NY 10002 EVENT FACILITATOR 307479 INTERNATIONAL CREATIVE MGMT 10250 CONSTELLATION BLVD LOS ANGELES CA 90067 ENTERNTAINMENT FOR EVENT 264400 BLACKBAUD PO BOX 930256 ATLANTA GA 31193 ONLINE FUNDRAISING FEES 226348 9 148751 8123929 14473852 10069400 22746532 CONTRACT REVENUE 900099 132603 132603 CONFERENCE FEES & SPONSORSHIPS 900099 3400 3400 136003 4287697 4287697 819 819 40060335 42161873 -2101538 -2101538 -2101538 519880 8123929 1136157 -616277 -616277 36545 32161 4384 4384 FFB CRI SERVICE FEES 900099 99996 99996 SUBLEASE INCOME 900099 32473 32473 MISCELLANEOUS 900099 95 95 132564 24590184 136003 0 1707649 13012583 13012583 2450052 2450052 1630606 560680 538224 531702 4171095 1195016 541389 2434690 61668 27233 7743 26692 504607 128189 88876 287542 387656 113624 67609 206423 21530 21530 77848 74050 3798 593653 593653 288185 272213 15972 928357 361081 230678 336598 1389662 189905 393292 806465 280955 23534 66957 190464 681669 87836 136401 457432 356980 98726 28019 230235 420707 224555 119011 77141 303587 182656 16633 104298 171167 49537 28793 92837 PRINTING & PRODUCTION 942758 118632 18734 805392 28675325 18823839 2628622 7222864 7866370 5745318 58062 59090 52027864 35451197 973081 2672556 864166 695130 5850235 4292057 1630411 1558178 88241116 100863588 6689509 6740654 332804 434858 158683383 154220569 3334625 3349297 9080648 10446066 1145809 826220 1619541 1673278 15180623 16294861 X 21880084 23730443 118432676 110938517 3190000 3256748 143502760 137925708 158683383 154220569 X -4085141 -1577901 85990 X 0 1 X 1 0 X 40828587 37077623 56098521 68515510 22746532 225266773 40828587 37077623 56098521 68515510 22746532 225266773 77925515 147341258 2360118 2787360 2753831 4764598 4320989 16986896 112380 107417 102294 102691 100091 524873 242778542 5121738 0.60690 0.58530 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: FFB CRI SERVICE FEES - 2012 AMOUNT: $ 99,900. 2013 AMOUNT: $ 99,900. 2014 AMOUNT: $ 100,000. 2015 AMOUNT: $ 99,996. 2016 AMOUNT: $ 99,996. RESEARCH PATENT - 2012 AMOUNT: $ 12,480. 2013 AMOUNT: $ 7,517. 2014 AMOUNT: $ 0. 2015 AMOUNT: $ 0. 2016 AMOUNT: $ 0. MISCELLANEOUS - 2012 AMOUNT: $ 0. 2013 AMOUNT: $ 0. 2014 AMOUNT: $ 2,294. 2015 AMOUNT: $ 2,695. 2016 AMOUNT: $ 95. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3190000 66748 17173 15012 0 2161 3256748 500000 2690000 23270 21049 2221 3190000 500000 30311 28140 2171 500000 500000 21205 19117 2088 500000 500000 14507 12469 2038 500000 0.00000 1.00000 0.00000 0 0 1405107 1156449 248658 867698 545097 322601 3577430 2590511 986919 1558178 POOLED INCOME FUND OBLIGATION 4812 CHARITABLE GIFT ANNUITY OBLIGATION 736676 DEFERRED COMPENSATION OBLIGATION 931790 1673278 X 23262686 -1577901 214974 5468782 4105855 19156831 5433353 5433353 24590184 28171194 214974 4800240 5015214 23155980 5519345 5519345 28675325 PART V, LINE 4: EARNINGS CAN BE USED FOR OPERATIONS; PRINCIPAL IS PERMANENTLY RESTRICTED. PART X, LINE 2: FFB PERFORMED AN EVALUATION OF ITS UNCERTAINTY IN INCOME TAX FOR THE YEARS ENDED JUNE 30, 2017 AND 2016, AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE CONSOLIDATED FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. PART XI, LINE 2D - OTHER ADJUSTMENTS: SUBSIDIARY REVENUE INCLUDED IN CONSOLIDATED FINANCIAL STATEMENTS 5,468,782. PART XI, LINE 4B - OTHER ADJUSTMENTS: INTERCOMPANY GRANTS AND MANAGEMENT FEE 5,433,353. PART XII, LINE 2D - OTHER ADJUSTMENTS: SUBSIDIARY EXPENSES INCLUDED IN CONSOLIDATED FINANCIAL STATEMENTS 4,800,240. PART XII, LINE 4B - OTHER ADJUSTMENTS: INTERCOMPANY GRANTS AND MANAGEMENT FEE 5,433,353. GRANT REFUNDS FROM DOMESTIC ORGANIZATION 85,992. 1 EUROPE (INCLUDING ICELAND AND GREENLAND) 0 0 GRANTMAKING 2225052 NORTH AMERICA 0 0 GRANTMAKING 150000 EAST ASIA AND THE PACIFIC 0 0 GRANTMAKING 75000 0 0 0 0 0 0 2450052 0 2450052 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 1447268 CHECK EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 500593 CHECK EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 100000 CHECK EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 51791 CHECK NORTH AMERICA RESEARCH 75000 CHECK NORTH AMERICA RESEARCH 75000 CHECK EAST ASIA AND THE PACIFIC RESEARCH 75000 CHECK EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 125400 CHECK 0 8 0 0 0 0 0 0 PART I, LINE 2: EACH GRANTEE IS REQUIRED TO SUBMIT A YEARLY SCIENTIFIC PROGRESS REPORT, WHICH IS REVIEWED BY THE FFB SCIENCE STAFF AND COMPARED WITH THE PROPOSED MILESTONES SUBMITTED WITH THE ORIGINAL GRANT APPLICATION. ATTENTION IS ALSO GIVEN TO THE PLAN FOR EXPERIMENTS TO BE PERFORMED IN THE COMING YEAR. ANY PROBLEMS OR ISSUES IDENTIFIED BY THE GRANTEE AND/OR FFB SCIENTIFIC STAFF ARE RESOLVED TO OUR MUTUAL SATISFACTION; HOWEVER, IF A CONSENSUS CANNOT BE REACHED OR IF THE APPARENT PROGRESS IS NOT SATISFACTORY IN THE OPINION OF FFB SCIENTIFIC STAFF, AFTER CONSULTATION WITH MEMBERS OF THE FFB SCIENTIFIC ADVISORY BOARD, THE GRANT IS TERMINATED WITH A SHORT PHASE OUT PERIOD. EACH GRANTEE IS REQUIRED TO SUBMIT A YEARLY FINANCIAL REPORT DETAILING GRANT EXPENDITURES ACCORDING TO THEIR FFB APPROVED GRANT BUDGET. SCIENCE STAFF REVIEW EACH FINANCIAL REPORT FOR ADHERENCE TO BUDGETED EXPENDITURES IN EACH CATEGORY. WITH PROPER DOCUMENTATION AND IF DETERMINED APPROPRIATE, REQUESTS FOR CARRYOVER OF UNEXPENDED FUNDS TO THE NEXT FISCAL YEAR ARE REVIEWED AND APPROVED ON A CASE-BY-CASE BASIS. PART I, LINE 3: IN ACCORDANCE WITH IRS INSTRUCTIONS, ALL AMOUNTS REPORTED IN PARTS I AND II OF SCHEDULE F ARE REPORTED USING THE ACCRUAL BASIS OF ACCOUNTING WHICH IS THE SAME METHOD OF ACCOUNTING USED IN THE FINANCIAL STATEMENTS. X X X X X X 1 DINA BEAUMONT 9720 OWEN BROWN ROAD COLUMBIA MD 21045 SPECIAL EVENT FUNDRAISING COUNSEL 0 200290 49000 151290 CATALYST CREATIVE LLC 150 LAS VEGAS BOULEVARD N SUITE 2 LAS VEGAS NV 89101 FUNDRAISING COUNSEL 0 120837 273461 -152624 THE HERITAGE COMPANY 2402 WILDWOOD AVENUE NORTH LITTLE ROCK AR 72120 TELEMARKETING FUNDRAISING COUNSEL 0 109790 41692 68098 NNE MARKETING 724 MASSACHUSETTS AVENUE ARLINGTON MA 02476 FUNDRAISING COUNSEL 0 0 229500 -229500 430917 593653 -162736 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VA WA WV WI WY DINNER - CHICAGO VISION BALL 1064219 984571 79648 95354 32350 14957 DINNER - NY FASHION 427318 333568 93750 22973 90612 2500 15180 61 7152272 6805790 346482 424732 326599 65822 45078 8643809 8123929 519880 447705 512565 100672 75215 1136157 -616277 36545 32161 0 36545 32161 32161 4384 FL IL MA MD MN MO NY 1 0 0 0 ANNETTE HINKLE CPA 7168 COLUMBIA GATEWAY DRIVE SUITE 1 COLUMBIA MD 21046 0 ANNETTE HINKLE CPA 104505 X 0 1 AUGUSTA UNIVERSITY RESEARCH INSTITUTE 1120 15TH STREET AUGUSTA GA 30912 586002053 501(C)(3) 100000 RESEARCH BUCK INSTITUTE ON AGING 8001 REDWOOD BOULEVARD NOVATO CA 94945 943030609 501(C)(3) 40000 RESEARCH CASE WESTERN RESERVE UNIVERSITY 10900 EUCLID AVENUE CLEVELAND OH 44106 341018992 501(C)(3) 35000 RESEARCH COLUMBIA UNIVERSITY 635 WEST 165TH STREET NEW YORK NY 10032 135598093 501(C)(3) 50000 RESEARCH DUKE UNIVERSITY MEDICAL CENTER 2200 W MAINE STREET DURHAM NC 27705 560532129 501(C)(3) 99999 RESEARCH DUKE UNIVERSITY MEDICAL CENTER 2200 W MAINE STREET DURHAM NC 27705 560532129 501(C)(3) 100000 RESEARCH FLORIDA STATE UNIVERSITY 600 W COLLEGE AVENUE TALLAHASSEE FL 32306 596152180 501(C)(3) 100000 RESEARCH FOUNDATION FIGHTING BLINDNESS CLINICAL RESEARCH INSTITUTE 7168 COLUMBIA GATEWAY DRIVE COLUMBIA MD 21046 450524687 501(C)(3) 5333359 RESEARCH HARVARD UNIVERSITY PO BOX 415649 HARVARD MA 02241 042103580 501(C)(3) 43000 RESEARCH JOHNS HOPKINS UNIVERSITY 600 NORTH WOLFE STREET BALTIMORE MD 21287 520595110 501(C)(3) 26341 RESEARCH JOHNS HOPKINS UNIVERSITY 600 NORTH WOLFE STREET BALTIMORE MD 21287 520595110 501(C)(3) 150000 RESEARCH JOHNS HOPKINS UNIVERSITY 600 NORTH WOLFE STREET BALTIMORE MD 21287 520595110 501(C)(3) 190000 RESEARCH JOHNS HOPKINS UNIVERSITY 600 NORTH WOLFE STREET BALTIMORE MD 21287 520595110 501(C)(3) 200000 RESEARCH LOUISIANA STATE UNIVERSITY 2020 GRAVIER STREET NEW ORLEANS LA 70803 721304948 501(C)(3) 282790 RESEARCH MASSACHUSETTS EYE AND EAR INFIRMARY 243 CHARLES STREET BOSTON MA 02114 042103591 501(C)(3) 100000 RESEARCH MASSACHUSETTS EYE AND EAR INFIRMARY 243 CHARLES STREET BOSTON MA 02114 042103591 501(C)(3) 170000 RESEARCH MASSACHUSETTS EYE AND EAR INFIRMARY 243 CHARLES STREET BOSTON MA 02114 042103591 501(C)(3) 211336 RESEARCH MASSACHUSETTS EYE AND EAR INFIRMARY 243 CHARLES STREET BOSTON MA 02114 042103591 501(C)(3) 500000 RESEARCH MICHIGAN STATE 426 AUDITORIUM ROAD EAST LANSING MI 48824 386005984 501(C)(3) 97385 RESEARCH OREGON HEALTH AND SCIENCE UNIVERSITY 3375 TERWILLIGER BOULEVARD SW PORTLAND OR 97201 237083114 501(C)(3) 75000 RESEARCH OREGON HEALTH AND SCIENCE UNIVERSITY 3375 TERWILLIGER BOULEVARD SW PORTLAND OR 97201 237083114 501(C)(3) 168106 RESEARCH REGENTS UNIV OF CALIFORNIA 10889 WILSHIRE BOULEVARD LOS ANGELES CA 90095 943067788 501(C)(3) 100000 RESEARCH RESEARCH FOUNDATION OF SUNY 520 LEE ENTRANCE AMHERST NY 14228 141368361 501(C)(3) 90020 RESEARCH RETINA FOUNDATION OF THE SOUTHWEST 9900 NORTH CENTRAL EXPRESSWAY DALLAS TX 75231 510151514 501(C)(3) 197100 RESEARCH SHILEY EYE CENTER 9500 GILMAN DRIVE MC 0009 LA JOLLA CA 92093 956006144 501(C)(3) 100000 RESEARCH STANFORD UNIVERSITY SCHOOL OF MEDICINE SUMC RM L-331 STANFORD CA 94305 941156365 501(C)(3) 100000 RESEARCH THE CLEVELAND CLINIC FOUNDATION 9500 EUCLID AVENUE CLEVELAND OH 44195 340714585 501(C)(3) 336371 RESEARCH THE JACKSON LABORATORY 600 MAIN STREET BAR HARBOR ME 04609 010221513 501(C)(3) 100000 RESEARCH UNIVERSITY OF MIAMI 1638 NW 10TH AVENUE MIAMI FL 33136 590624458 501(C)(3) 100000 RESEARCH UNIV OF N TX HEALTH AND SCIENCE CENTERE 3500 CAMP BOWIE BOULEVARD FORT WORTH TX 76107 756064033 501(C)(3) 75000 RESEARCH UNIVERSITY CALIFORNIA SAN FRANCISCO 100 STEIN PLAZA LOS ANGELES CA 90095 956006143 501(C)(3) 498215 RESEARCH UNIVERSITY HOSPITALS UH GRANTS DEPT 781686 PO BOX 78000 DETROIT MI 48278 341567805 501(C)(3) 800624 RESEARCH UNIVERSITY OF CALIFORNIA BERKELEY 2150 SHATTUCK AVENUE BERKELEY CA 94720 946002123 501(C)(3) 126814 RESEARCH UNIVERSITY OF CALIFORNIA BERKELEY 2150 SHATTUCK AVENUE BERKELEY CA 94720 946002123 501(C)(3) 206718 RESEARCH UNIVERSITY OF FLORIDA PO BOX 100284 GAINESVILLE FL 32610 592729133 501(C)(3) 50000 RESEARCH UNIVERSITY OF HOUSTON 4302 UNVERSITY DRIVE ROOM 316 HOUSTON TX 77204 746001399 501(C)(3) 56462 RESEARCH UNIVERSITY OF MICHIGAN 100 WALL STREET ANN ARBOR MI 48105 386006309 501(C)(3) 99973 RESEARCH UNIVERSITY OF OKLAHOMA HEALTH SCIENCES 608 STANTON L YOUNG BOULEVARD OKLAHOMA CITY OK 73104 730762267 501(C)(3) 63750 RESEARCH UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET PHILADELPHIA PA 19104 232810852 501(C)(3) 26350 RESEARCH UNIVERSITY OF PENNSYLVANIA 422 CURIE BOULEVARD PHILADELPHIA PA 19104 232810852 501(C)(3) 70000 RESEARCH UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET PHILADELPHIA PA 19104 232810852 501(C)(3) 140000 RESEARCH UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET PHILADELPHIA PA 19104 232810852 501(C)(3) 400000 RESEARCH UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET PHILADELPHIA PA 19104 232810852 501(C)(3) 500000 RESEARCH UNIVERSITY OF ROCHESTER 513 HYLAND BUILDING PO BOX 270140 ROCHESTER NY 14627 160743209 501(C)(3) 99777 RESEARCH UNIVERSITY OF TENNESSEE 910 MADISON AVENUE SUITE 823 MEMPHIS TN 38163 626001636 501(C)(3) 31875 RESEARCH UNIVERSITY OF TEXAS HEALTH SCIENCE 1200 HERMAN PRESSLER DRIVE HOUSTON TX 77030 741761309 501(C)(3) 95066 RESEARCH UNIVERSITY OF WASHINGTON 1100 45TH STREET NE SEATTLE WA 98105 943079432 501(C)(3) 98617 RESEARCH UNIVERSITY OF WISCONSIN 21 NORTH PARK STREET MADISON WI 53715 390743975 501(C)(3) 150000 RESEARCH UNIVERSITY OF WISCONSIN 21 NORTH PARK STREET MADISON WI 53715 390743975 501(C)(3) 227535 RESEARCH 35 0 PART I, LINE 2: EACH GRANTEE IS REQUIRED TO SUBMIT A YEARLY SCIENTIFIC PROGRESS REPORT, WHICH IS REVIEWED BY THE FFB SCIENCE STAFF AND COMPARED WITH THE PROPOSED MILESTONES SUBMITTED WITH THE ORIGINAL GRANT APPLICATION. ATTENTION IS ALSO GIVEN TO THE PLAN FOR EXPERIMENTS TO BE PERFORMED IN THE COMING YEAR. ANY PROBLEMS OR ISSUES IDENTIFIED BY THE GRANTEE AND/OR FFB SCIENTIFIC STAFF ARE RESOLVED TO OUR MUTUAL SATISFACTION; HOWEVER, IF A CONSENSUS CANNOT BE REACHED OR IF THE APPARENT PROGRESS IS NOT SATISFACTORY IN THE OPINION OF FFB SCIENTIFIC STAFF, AFTER CONSULTATION WITH MEMBERS OF THE FFB SCIENTIFIC ADVISORY BOARD, THE GRANT IS TERMINATED WITH A SHORT PHASE OUT PERIOD. EACH GRANTEE IS REQUIRED TO SUBMIT A YEARLY FINANCIAL REPORT DETAILING GRANT EXPENDITURES ACCORDING TO THEIR FFB APPROVED GRANT BUDGET. SCIENCE STAFF REVIEW EACH FINANCIAL REPORT FOR ADHERENCE TO BUDGETED EXPENDITURES IN EACH CATEGORY. WITH PROPER DOCUMENTATION AND IF DETERMINED APPROPRIATE, REQUESTS FOR CARRYOVER OF UNEXPENDED FUNDS TO THE NEXT FISCAL YEAR ARE REVIEWED AND APPROVED ON A CASE-BY-CASE BASIS. X X X X X 0 0 0 0 0 0 0 0 0 WILLIAM T SCHMIDT CHIEF EXECUTIVE OFFICER 354215 0 0 0 0 0 7950 0 1991 0 364156 0 0 0 PATRICIA ZILLIOX PHD CHIEF DRUG DEVELOPMENT OFFICER 0 234752 0 0 0 0 0 7005 0 2197 0 243954 0 0 STEPHEN M ROSE PHD CHIEF RESEARCH OFFICER 225486 0 0 0 0 0 6980 0 21977 0 254443 0 0 0 PATRICIA A DUDLEY CHIEF HUMAN RESOURCE OFFICER 146480 0 0 0 0 0 4249 0 21511 0 172240 0 0 0 LORRAINE HIRSCH CPA CHIEF FINAN. OFFICER - UNTIL 03/2017 178942 0 0 0 0 0 5496 0 15775 0 200213 0 0 0 VALERIE NAVY-DANIELS CHIEF DEVELOPMENT OFFICER 259338 0 0 0 0 0 7950 0 21735 0 289023 0 0 0 RHEA FARBERMAN DEPUTY CHIEF, DEVELOPMENT 154126 0 0 0 0 0 4543 0 8272 0 166941 0 0 0 HOPE KESSLER SR. DIRECTOR, MAJOR GIFTS 236066 0 0 0 0 0 2361 0 15238 0 253665 0 0 0 BRIAN MANSFIELD PHD DEPUTY CHIEF RESEARCH OFFICER 162710 0 0 0 0 0 5151 0 21746 0 189607 0 0 0 X 45 9524104 FAIR MARKET VALUE X AUCTION ITEMS 1 452356 FAIR MARKET VALUE X AWARDS 1 55000 FAIR MARKET VALUE X EVENT ITEMS 1 37940 FAIR MARKET VALUE 1 0 1 1 PART I, COLUMN (B): THE NUMBER IN THIS COLUMN REPRESENTS THE NUMBER OF CONTRIBUTIONS. PART I, LINE 32B: WHEN DONATED STOCK IS RECEIVED, OUR BROKER MERRILL LYNCH IMMEDIATELY CONVERTS THESE CONTRIBUTIONS INTO CASH. FORM 990, PART VI, SECTION A, LINE 2 EDWARD RUSSNOW, VICE CHAIRMAN, HAS A FAMILY RELATIONSHIP WITH EDWARD H. GOLLOB, BOD PRESIDENT EMERITUS. FORM 990, PART VI, SECTION A, LINE 6 MEMBERS OF FFB ARE KNOWN AS NATIONAL TRUSTEES. THE QUALIFICATIONS AND ELIGIBILITY FOR MEMBERSHIP AND THE MANNER OF ADMISSION INTO MEMBERSHIP IS PRESCRIBED BY RESOLUTION OF THE BOARD OF DIRECTORS. THE NATIONAL TRUSTEES ARE ENTITLED TO VOTE ON ELECTION OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7A DURING THE ANNUAL MEETING OF THE NATIONAL TRUSTEES, MEMBERS OF THE BOARD OF DIRECTORS ARE ELECTED. FORM 990, PART VI, SECTION B, LINE 11B DATA TO PREPARE THE FEDERAL FORM 990 IS PROVIDED TO OUR OUTSIDE ACCOUNTING FIRM FOR PREPARATION AND GUIDANCE. AFTER IT HAS BEEN COMPLETED, A DRAFT OF THE FEDERAL FORM 990 IS REVIEWED BY THE CHIEF FINANCIAL OFFICER. WITH THE CFO'S APPROVAL THE DRAFT FEDERAL FORM 990 IS THEN MADE AVAILABLE TO ALL BOARD MEMBERS. ALL BOARD MEMBERS ARE INVITED TO ATTEND A SPECIAL MEETING OF THE FINANCE COMMITTEE TO REVIEW THE FEDERAL FORM 990. A FINAL DRAFT IS MADE AVAILABLE TO ALL BOARD MEMBERS BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST POLICY FORMS ARE OBTAINED UPON BOARD ELECTION AND HIRING. NEW FORMS ARE OBTAINED AT THE BEGINNING OF EVERY FISCAL YEAR. SENIOR MANAGEMENT AND BOARD MEMBERS ARE AWARE THAT CONFLICT OF INTERESTS MUST BE DOCUMENTED AND DISCLOSED TO THE BOARD OF DIRECTORS. FINANCE STAFF REVIEW ACTIVITY THROUGHOUT THE YEAR FOR PROPER DISCLOSURE. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION COMMITTEE AND THE BOARD OF DIRECTORS APPROVES THE COMPENSATION OF THE CHIEF EXECUTIVE OFFICER. THE COMPENSATION COMMITTEE APPROVES THE COMPENSATION OF THE OTHER CHIEF OFFICERS. ON A ROUTINE BASIS, EXTERNAL DATA PROVIDED BY OUTSIDE EXPERT COMPENSATION CONSULTANTS IS USED TO MEASURE REASONABLENESS OF SALARIES TO THE MARKET PLACE AND RESULTS ARE COMMUNICATED BY OUTSIDE CONSULTANTS TO THE BOARD CHAIR/COMPENSATION COMMITTEE. FORM 990, PART VI, SECTION C, LINE 19 FFB'S FEDERAL FORM 990 AND CONSOLIDATED AUDITED FINANCIAL STATEMENTS ARE AVAILABLE AT WWW.FIGHTBLINDNESS.ORG. OTHER PUBLIC GOVERNING DOCUMENTS INCLUDING THE CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST THROUGH THE CONTACT INFORMATION DISCLOSED ON FFB'S WEB SITE. FORM 990, PART VII, SECTION A: FFB ACTS AS THE COMMON PAYMASTER FOR THE FOUNDATION FIGHTING BLINDNESS CLINICAL RESEARCH INSTITUTE, A RELATED ORGANIZATION. FORM 990, PART XI, LINE 9: GRANT REFUNDS FROM DOMESTIC ORGANIZATIONS 85,990. FOUNDATION FIGHTING BLINDNESS CLINICAL RESEARCH INSTITUTE 7168 COLUMBIA GATEWAY DRIVE SUITE 1 COLUMBIA MD 21046 450524687 RESEARCH DE 501(C)(3) LINE 11A FOUNDATION FIGHTING BLINDNESS 1 MACULAR DEGENERATION INTERNATIONAL INC 7168 COLUMBIA GATEWAY DRIVE SUITE 1 COLUMBIA MD 21046 363923922 FUNDRAISING IL 501(C)(3) LINE 7 FOUNDATION FIGHTING BLINDNESS 1 NATIONAL RETINITIS PIGMENTOSA FOUNDATION INC 7168 COLUMBIA GATEWAY DRIVE SUITE 1 COLUMBIA MD 21046 522072391 FUNDRAISING MD 501(C)(3) LINE 11A FOUNDATION FIGHTING BLINDNESS 1 0 1 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 FOUNDATION FIGHTING BLINDNESS CLINICAL RESEARCH INSTITUTE B 5333359 FMV FOUNDATION FIGHTING BLINDNESS CLINICAL RESEARCH INSTITUTE L 99996 FMV FOUNDATION FIGHTING BLINDNESS CLINICAL RESEARCH INSTITUTE O 374569 FMV